Litigation Details for Intendis GmbH v. Glenmark Pharmaceuticals Inc. (Fed. Cir. 2015)
✉ Email this page to a colleague
Intendis GmbH v. Glenmark Pharmaceuticals Inc. (Fed. Cir. 2015)
Docket | ⤷ Sign Up | Date Filed | 2015-08-05 |
Court | Court of Appeals for the Federal Circuit | Date Terminated | |
Cause | Assigned To | ||
Jury Demand | Referred To | ||
Patents | 6,534,070 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Intendis GmbH v. Glenmark Pharmaceuticals Inc.
Details for Intendis GmbH v. Glenmark Pharmaceuticals Inc. (Fed. Cir. 2015)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2015-09-04 | 20 | assignee of U.S. Patent No. 6,534,070 ("the '070 patent") ("the patent-in-suit")…TABLE OF ABBREVIATIONS ’070 patent United States Patent No. 6,534,070 (A3877-84) ’163 PCT …...................... A73-74 Patent-in-Suit: U.S. Patent No. 6,534,070 ..............................…FROM THE RECORDS OF THIS OFFICE OF: U.S. PATENT: 6,534,070 ISSUE DATE: March 18,2003 … US 6,534,070 Bl Franke et al. | External link to document | |
2015-10-21 | 25 | TABLE OF ABBREVIATIONS ’070 patent U.S. Patent No. 6,534,070 ’070 prosecution Prosecution…Court correctly found Bayer’s U.S. Patent No. 6,534,070 (“’070 patent”) on novel azelaic acid hydrogels…Application Publication No. WO 93/18752 ’943 patent U.S. Patent No. 5,385,943 ANDA …the subject of ANDA No. 204637 Glenmark’s patent U.S. Patent Application Publication US 2010/0004338 …based on the ’070 patent’s reported penetration data, as well as Glenmark’s own patent application, Franz | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |